Latest filing published 08 May 2015 for HYPERION THERAPEUTICS INC, €107k.
No signal scores available.
Bo Jesper Hansen discloses dealings in Hyperion Therapeutics Inc to SEC (Form 4). Over a trading history stretching from 27 May 2014 to 7 May 2015, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 8 May 2015 with a transaction (€107k) in Hyperion Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations